Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Dexcom (DXCM) over the last 17 years, with Q3 2025 value amounting to $2.9 million.

  • Dexcom's Current Deferred Revenue fell 7913.67% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 7913.67%. This contributed to the annual value of $8.0 million for FY2024, which is 5652.17% down from last year.
  • Dexcom's Current Deferred Revenue amounted to $2.9 million in Q3 2025, which was down 7913.67% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Dexcom's Current Deferred Revenue registered a high of $18.4 million during Q4 2023, and its lowest value of $1.8 million during Q2 2021.
  • Moreover, its 5-year median value for Current Deferred Revenue was $7.8 million (2025), whereas its average is $7.5 million.
  • As far as peak fluctuations go, Dexcom's Current Deferred Revenue soared by 38095.24% in 2022, and later crashed by 7913.67% in 2025.
  • Over the past 5 years, Dexcom's Current Deferred Revenue (Quarter) stood at $2.1 million in 2021, then skyrocketed by 380.95% to $10.1 million in 2022, then soared by 82.18% to $18.4 million in 2023, then crashed by 56.52% to $8.0 million in 2024, then plummeted by 63.75% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q3 2025, $6.1 million for Q2 2025, and $7.8 million during Q1 2025.